The Coronary Stents Market Forecast to 2028 – Global the market size is expected to grow from US$ 7,223.2 million in 2016 to US$ 13,879.0 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2016 to 2028. Coronary stents are small, expandable tubes usually made of metal mesh to treat narrowed arteries in the body. In individuals with coronary heart disease caused by plaque build up, coronary stents can open narrowed arteries, reduce symptoms such as chest pain and help treat a heart attack. The stent helps prop the artery open, decreasing its chance of narrowing again. Most stents are coated with a drug (drug-eluting stents) to assist in keeping the artery open. Coronary stents are put into arteries after expanding the artery. This process is called percutaneous coronary intervention or coronary angioplasty.

Rising Geriatric Population Fuels Coronary Stents Market Value and Growth 

The geriatric population is prone to heart disorders due to weak immunity and other related health problems. For instance, the number of Americans aged 65 and older is expected to grow from 46 million in 2016 to 98 million by 2060. The 65 years and older age group's share in the world's population is expected to increase around 24% from 15%.

Get Sample Pdf:- https://www.theinsightpartners.com/sample/TIPHE100000827/

Market Insights

Cardiovascular diseases are the foremost cause of death across the globe. In 2015, approximately 17.7 million people died from CVDs, accounting for 31% of all global deaths. About 6.7 million were because of stroke, and 7.4 million were due to coronary heart disease. Among those 17 million deaths, around 82.0% of casualties were reported in low and middle-income countries. The growing fatalities propel the need and demand for coronary stents to treat CVDs, which is subsequently likely to increase the coronary stents market size and thus market value in the future years.

Type-Based Insights

Based on type, the global coronary stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. In 2017, the drug-eluting stents segment held the largest market share and is expected to register the highest CAGR during the forecast period owing to the advantages of the drug-eluting stents that lower the risk of complications.

Absorption Rate-Based Insights

Based on absorption rate, the global coronary stents market is bifurcated into fast-absorption rate stents and slow-absorption rate stents. In 2017, the slow-absorption rate stents segment held a larger market share and is expected to register a higher CAGR during 2016–2025. Slow-absorption rate stents are preferred by physicians and patients owing to the slow rate of drug elution by the stent, which in turn, decreases the risk of blockage over the time.

Material-Based Insights

Based on material, the global coronary stents market is segmented into cobalt, platinum, nickel, stainless steel, nitinol, tantalum, polymer, and gold. In 2017, the cobalt segment held the largest market share and is expected to register the highest CAGR during 2016–2025. The factors attributing the growth of this segment is higher radial strength and radio-opacity of cobalt for similar electronegativity.

End User-Based Insights

Based on end users, the global coronary stents market is segmented into hospital, ambulatory surgical centers, and cardiac centers. In 2017, the hospital segment held the largest market share and is expected to register the highest CAGR during 2016–2025.

Coronary Stents Market, by Type – 2017 and 2025

Get more information on this report : Request Free Sample PDF

Strategic Insights

Buy Now:- https://www.theinsightpartners.com/buy/TIPHE100000827/

The coronary stents market report offers the organic and inorganic strategies adopted by the key players operating in the market. Product launches and collaborations are highly adopted strategies by the global market players. A few of the recent key market developments are listed below:

• In February 2018, Medtronic announced to have FDA approval for resolute onyx, their first drug-eluting stent in the market. The company also launched the product in US.
• In February 2018, Stentys, a medical technology company, announced that it had acquired the Minvasys for business expansion

Company Profiles

• MicroPort Scientific Corporation
• Translumina GmbH
• Abbott Laboratories
• Terumo Corporation
• Medtronic
• BIOSENSORS INTERNATIONAL GROUP, LTD.
• STENTYS SA
• Vascular Concepts
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876